Related Experiment Videos
[Staged analgesic therapy in tumor pain]
1Klinik für Anästhesiologie, Intensiv- und Schmerztherapiel, Universitätsklinik Bergmannsheil, Bochum.
Praxis
|October 23, 1998
Summary
Effective cancer pain management relies on the World Health Organization (WHO) analgesic ladder, prioritizing non-opioid analgesics and "weak" opioids for mild to moderate pain. This approach ensures optimal pain relief for most patients, maintaining quality of life.
Area of Science:
- Oncology
- Pain Management
- Pharmacology
Context:
- Cancer pain is a prevalent and distressing symptom, significantly impacting patient well-being.
- Pain management strategies are crucial for improving the quality of life for cancer patients.
- Drug selection for cancer pain is primarily guided by pain intensity, not specific pathophysiology.
Purpose:
- To outline effective strategies for managing cancer pain.
- To describe the application of the World Health Organization (WHO) analgesic ladder.
- To highlight the role of various analgesics and administration routes in cancer pain control.
Summary:
- Mild to moderate cancer pain can be managed with non-opioid analgesics and weak opioids, following the WHO analgesic ladder.
- Consistent dosing schedules and rescue doses are essential for managing breakthrough pain.
- Non-invasive routes of administration are preferred to maintain patient independence, with infusion therapy and patient-controlled analgesia (PCA) as options for severe cases.
- Co-analgesics like antidepressants and anticonvulsants can be used adjunctively.
- Oral medication provides effective pain relief for approximately 95% of cancer patients.
Impact:
- The WHO analgesic ladder provides a proven framework for effective cancer pain management across diverse care settings.
- Optimized pain management improves patient outcomes and reduces anticipatory distress associated with cancer.
- Maintaining non-invasive routes of administration supports patient mobility and autonomy.